GE HEALTHCARE TECHNOLOGY (GEHC) Fundamental Analysis & Valuation
NASDAQ:GEHC • US36266G1076
Current stock price
69.65 USD
-0.73 (-1.04%)
At close:
69.67 USD
+0.02 (+0.03%)
After Hours:
This GEHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GEHC Profitability Analysis
1.1 Basic Checks
- In the past year GEHC was profitable.
- GEHC had a positive operating cash flow in the past year.
- In the past 5 years GEHC has always been profitable.
- Each year in the past 5 years GEHC had a positive operating cash flow.
1.2 Ratios
- GEHC has a better Return On Assets (5.65%) than 81.52% of its industry peers.
- Looking at the Return On Equity, with a value of 20.09%, GEHC belongs to the top of the industry, outperforming 94.57% of the companies in the same industry.
- GEHC's Return On Invested Capital of 7.81% is amongst the best of the industry. GEHC outperforms 82.07% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for GEHC is in line with the industry average of 9.18%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.65% | ||
| ROE | 20.09% | ||
| ROIC | 7.81% |
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
1.3 Margins
- With an excellent Profit Margin value of 10.11%, GEHC belongs to the best of the industry, outperforming 83.15% of the companies in the same industry.
- GEHC's Profit Margin has declined in the last couple of years.
- The Operating Margin of GEHC (13.40%) is better than 80.43% of its industry peers.
- In the last couple of years the Operating Margin of GEHC has declined.
- GEHC has a worse Gross Margin (39.98%) than 67.39% of its industry peers.
- GEHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.4% | ||
| PM (TTM) | 10.11% | ||
| GM | 39.98% |
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
2. GEHC Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GEHC is destroying value.
- GEHC has less shares outstanding than it did 1 year ago.
- GEHC has more shares outstanding than it did 5 years ago.
- GEHC has about the same debt/assets ratio as last year.
2.2 Solvency
- GEHC has an Altman-Z score of 1.84. This is not the best score and indicates that GEHC is in the grey zone with still only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 1.84, GEHC is in line with its industry, outperforming 58.15% of the companies in the same industry.
- GEHC has a debt to FCF ratio of 6.67. This is a slightly negative value and a sign of low solvency as GEHC would need 6.67 years to pay back of all of its debts.
- GEHC has a better Debt to FCF ratio (6.67) than 75.54% of its industry peers.
- GEHC has a Debt/Equity ratio of 0.92. This is a neutral value indicating GEHC is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.92, GEHC is doing worse than 73.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | 6.67 | ||
| Altman-Z | 1.84 |
ROIC/WACC0.78
WACC9.97%
2.3 Liquidity
- A Current Ratio of 1.37 indicates that GEHC should not have too much problems paying its short term obligations.
- GEHC's Current ratio of 1.37 is on the low side compared to the rest of the industry. GEHC is outperformed by 78.80% of its industry peers.
- GEHC has a Quick Ratio of 1.13. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
- With a Quick ratio value of 1.13, GEHC is not doing good in the industry: 73.91% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.13 |
3. GEHC Growth Analysis
3.1 Past
- The Earnings Per Share has been growing slightly by 2.00% over the past year.
- The earnings per share for GEHC have been decreasing by -31.63% on average. This is quite bad
- The Revenue has been growing slightly by 4.85% in the past year.
- The Revenue has been growing slightly by 3.74% on average over the past years.
EPS 1Y (TTM)2%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-0.69%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.13%
3.2 Future
- GEHC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.20% yearly.
- Based on estimates for the next years, GEHC will show a small growth in Revenue. The Revenue will grow by 4.05% on average per year.
EPS Next Y12.85%
EPS Next 2Y11.37%
EPS Next 3Y11.08%
EPS Next 5Y8.2%
Revenue Next Year5.48%
Revenue Next 2Y4.99%
Revenue Next 3Y4.9%
Revenue Next 5Y4.05%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. GEHC Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 15.21, which indicates a correct valuation of GEHC.
- Based on the Price/Earnings ratio, GEHC is valued cheaply inside the industry as 86.41% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Earnings ratio of 25.23, GEHC is valued a bit cheaper.
- Based on the Price/Forward Earnings ratio of 13.48, the valuation of GEHC can be described as correct.
- 88.59% of the companies in the same industry are more expensive than GEHC, based on the Price/Forward Earnings ratio.
- GEHC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.28, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.21 | ||
| Fwd PE | 13.48 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, GEHC is valued cheaply inside the industry as 88.59% of the companies are valued more expensively.
- 86.41% of the companies in the same industry are more expensive than GEHC, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.09 | ||
| EV/EBITDA | 11.26 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- GEHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.18
PEG (5Y)N/A
EPS Next 2Y11.37%
EPS Next 3Y11.08%
5. GEHC Dividend Analysis
5.1 Amount
- GEHC has a yearly dividend return of 0.20%, which is pretty low.
- GEHC's Dividend Yield is rather good when compared to the industry average which is at 0.24. GEHC pays more dividend than 89.67% of the companies in the same industry.
- With a Dividend Yield of 0.20, GEHC pays less dividend than the S&P500 average, which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.2% |
5.2 History
- GEHC has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- GEHC pays out 3.07% of its income as dividend. This is a sustainable payout ratio.
DP3.07%
EPS Next 2Y11.37%
EPS Next 3Y11.08%
GEHC Fundamentals: All Metrics, Ratios and Statistics
69.65
-0.73 (-1.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)04-27 2026-04-27
Inst Owners93.29%
Inst Owner Change12.34%
Ins Owners0.3%
Ins Owner Change0.63%
Market Cap31.74B
Revenue(TTM)20.63B
Net Income(TTM)2.08B
Analysts78.57
Price Target95.29 (36.81%)
Short Float %2.4%
Short Ratio3.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.2% |
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP3.07%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-02 2026-04-02 (0.035)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.4%
Min EPS beat(2)-0.16%
Max EPS beat(2)0.96%
EPS beat(4)3
Avg EPS beat(4)5.61%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)4.83%
EPS beat(12)10
Avg EPS beat(12)5.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.59%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)-0.44%
Revenue beat(4)1
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)0.42%
Revenue beat(8)1
Avg Revenue beat(8)-1.72%
Revenue beat(12)2
Avg Revenue beat(12)-1.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.3%
PT rev (3m)6.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.69%
EPS NY rev (1m)2.9%
EPS NY rev (3m)3.15%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)0.61%
Revenue NY rev (1m)1.1%
Revenue NY rev (3m)1.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.21 | ||
| Fwd PE | 13.48 | ||
| P/S | 1.54 | ||
| P/FCF | 21.09 | ||
| P/OCF | 15.98 | ||
| P/B | 3.06 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.26 |
EPS(TTM)4.58
EY6.58%
EPS(NY)5.17
Fwd EY7.42%
FCF(TTM)3.3
FCFY4.74%
OCF(TTM)4.36
OCFY6.26%
SpS45.26
BVpS22.77
TBVpS-9.3
PEG (NY)1.18
PEG (5Y)N/A
Graham Number48.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.65% | ||
| ROE | 20.09% | ||
| ROCE | 9.94% | ||
| ROIC | 7.81% | ||
| ROICexc | 9.32% | ||
| ROICexgc | 25% | ||
| OM | 13.4% | ||
| PM (TTM) | 10.11% | ||
| GM | 39.98% | ||
| FCFM | 7.3% |
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
ROICexc(3y)9.48%
ROICexc(5y)10.1%
ROICexgc(3y)28.41%
ROICexgc(5y)36.05%
ROCE(3y)10.49%
ROCE(5y)11.63%
ROICexgc growth 3Y-16.74%
ROICexgc growth 5Y-17.72%
ROICexc growth 3Y-3.85%
ROICexc growth 5Y-6.16%
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
F-Score4
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | 6.67 | ||
| Debt/EBITDA | 2.85 | ||
| Cap/Depr | 83.39% | ||
| Cap/Sales | 2.34% | ||
| Interest Coverage | 5.29 | ||
| Cash Conversion | 59.47% | ||
| Profit Quality | 72.18% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 1.84 |
F-Score4
WACC9.97%
ROIC/WACC0.78
Cap/Depr(3y)71.99%
Cap/Depr(5y)60.92%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.89%
Profit Quality(3y)91.25%
Profit Quality(5y)85.67%
High Growth Momentum
Growth
EPS 1Y (TTM)2%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-0.69%
EPS Next Y12.85%
EPS Next 2Y11.37%
EPS Next 3Y11.08%
EPS Next 5Y8.2%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.13%
Revenue Next Year5.48%
Revenue Next 2Y4.99%
Revenue Next 3Y4.9%
Revenue Next 5Y4.05%
EBIT growth 1Y5.26%
EBIT growth 3Y3.09%
EBIT growth 5Y0.31%
EBIT Next Year31.3%
EBIT Next 3Y14.92%
EBIT Next 5Y12.12%
FCF growth 1Y-2.9%
FCF growth 3Y-5.84%
FCF growth 5Y-8.6%
OCF growth 1Y1.85%
OCF growth 3Y-2.03%
OCF growth 5Y-5.37%
GE HEALTHCARE TECHNOLOGY / GEHC Fundamental Analysis FAQ
What is the fundamental rating for GEHC stock?
ChartMill assigns a fundamental rating of 5 / 10 to GEHC.
What is the valuation status for GEHC stock?
ChartMill assigns a valuation rating of 7 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Undervalued.
How profitable is GE HEALTHCARE TECHNOLOGY (GEHC) stock?
GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.
What is the financial health of GE HEALTHCARE TECHNOLOGY (GEHC) stock?
The financial health rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10.
Can you provide the dividend sustainability for GEHC stock?
The dividend rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10 and the dividend payout ratio is 3.07%.